Dimebon improves learning in animals with experimental Alzheimer's disease

被引：57
|
作者：
Lermontova, NN [1 ]
Lukoyanov, NV [1 ]
Serkova, TP [1 ]
Lukoyanova, EA [1 ]
Bachurin, SO [1 ]
机构：
[1] Russian Acad Sci, Inst Physiol Act Subst, Neurochem Lab, Chernogolovka 142432, Moscow Region, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2000年 / 129卷 / 06期
基金：
俄罗斯基础研究基金会;
关键词：
dimebon; H-1 receptor inhibitor; tacrine; AF64A; avoidance conditioning; rats;
D O I：
10.1007/BF02434871
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Systemic administration of antihistamine drug dimebon improves active avoidance conditioning in rats with chronic partial deprivation of cerebral cholinergic functions caused by intracerebroventricular injections of AF64A. The effects of dimebon on learning are similar to those of tacrine used in the treatment of Alzheimer's disease.
引用
收藏
页码：544 / 546
页数：3
相关论文
共 50 条
  • [21] Dimebon™ is neuroprotective in a model of Parkinson's disease
    Staal, R. G. W.
    Kubek, K.
    Sung, A.
    Lin, Q.
    DenBleyker, M.
    Monaghan, M.
    Martone, R.
    Robichaud, A. J.
    Haydar, S. N.
    Pangalos, M.
    Reinhart, P. H.
    Hirst, W. D.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S110 - S110
  • [22] Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats
    Zhang, Jun
    Wei, Shu-Yu
    Yuan, Li
    Kong, Lin-Lin
    Zhang, Sheng-Xiao
    Wang, Zhao-Jun
    Wu, Mei-Na
    Qi, Jin-Shun
    PHYSIOLOGY & BEHAVIOR, 2017, 174 : 67 - 73
  • [23] [11C]Dimebon, radiosynthesis and lipophilicity of a new potential PET agent for imaging of Alzheimer's disease and Huntington's disease
    Gao, Mingzhang
    Wang, Min
    Hutchins, Gary D.
    Zheng, Qi-Huang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2529 - 2532
  • [24] Dimebon improves memory, orientation, language, and praxis in patients with mild to moderate Alzheimer's disease: Results of a one-year placebo-controlled study
    Ferris, Steuen
    Doody, Rochelle
    Gaurilova, Svetlana
    Sano, Mary
    Aisen, Paul
    Seely, Lynn
    NEUROLOGY, 2008, 70 (11) : A393 - A394
  • [25] Dimebon Stabilizes Neuropsychiatric Symptoms in Alzheimer's Disease: One-Year Clinical Trial Results
    Cuminings, Jeffrey I.
    Doody, Rachelle
    Gavrilova, Svetlana I.
    Sano, Mary
    Aisen, Paul S.
    Seely, Lynn
    Hung, David
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A111 - A111
  • [26] Experimental models in Alzheimer's disease
    Manzano, S.
    Gonzalez, J. L.
    Marcos, A.
    Payno, M.
    Villanueva, C.
    Matias-Guiu, J.
    NEUROLOGIA, 2009, 24 (04): : 255 - 262
  • [27] Prodromal dimethyl sulfoxide improves visual performance and rod hyperactivity in experimental Alzheimer's disease
    Abdul-Nabi, Mura
    Katz, Ryan
    Waseem, Rida
    Roberts, Robin
    Podolsky, Robert
    Bustos, Abner
    Berkowitz, Bruce A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [28] Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer's Disease
    Eckert, Schamim H.
    Gaca, Janett
    Kolesova, Nathalie
    Friedland, Kristina
    Eckert, Gunter P.
    Muller, Walter E.
    AGING AND DISEASE, 2018, 9 (04): : 729 - 744
  • [29] Classification learning in Alzheimer's disease
    Kéri, S
    Kálmán, J
    Rapcsak, SZ
    Antal, A
    Benedek, G
    Janka, Z
    BRAIN, 1999, 122 : 1063 - 1068
  • [30] Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease
    Farr, Susan A.
    Roesler, Elizabeth
    Niehoff, Michael L.
    Roby, Deborah A.
    McKee, Alexis
    Morley, John E.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1699 - 1710
12345